Goto T, et al. "Generation of pluripotent stem cell-derived mouse kidneys in Sall1-targeted anephric rats." Nat Commun. 2019 Feb 5;10(1):451. PubMed
Umezu D, et al. "Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment." Cancer Immunol Immunother. 2019 Feb;68(2):201-211. PubMed
Xu WH, et al. "Knockdown of KDM2A inhibits proliferation associated with TGF-β expression in HEK293T cell." Mol Cell Biochem. 2019 Jun;456(1-2):95-104. PubMed
Zou Y, et al. "A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis." Nat Commun. 2019 Apr 8;10(1):1617. PubMed
Mondal G, et al. "A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers." Nat Commun. 2019 Apr 11;10(1):1686 PubMed
Egbert RG, et al. "A versatile platform strain for high-fidelity multiplex genome editing." Nucleic Acids Res. 2019 Apr 8;47(6):3244-3256. PubMed
Hojo MA, et al. "Identification of a genomic enhancer that enforces proper apoptosis induction in thymic negative selection." Nat Commun. 2019 Jun 13;10(1):2603. PubMed
Ludwig LS, et al. "Transcriptional States and Chromatin Accessibility Underlying Human Erythropoiesis." Cell Rep. 2019 Jun 11;27(11):3228-3240.e7. PubMed
Narimatsu Y, et al. "An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells." Mol Cell. 2019 Jul 25;75(2):394-407.e5. PubMed
Tagaya H, et al. "A method of producing genetically manipulated mouse mammary gland." Breast Cancer Res. 2019 Jan 5;21(1):1. PubMed
Xu H, et al. "Determination of EPAC2 function using EPAC2 null Min6 sublines generated through CRISPR-Cas9 technology." Mol Cell Endocrinol. 2018 Sep 15;473:114-123. PubMed
Sakaguchi Y, et al. "Roles of Enhancer RNAs in RANKL-induced Osteoclast Differentiation Identified by Genome-wide Cap-analysis of Gene Expression using CRISPR/Cas9." Sci Rep. 2018 May 14;8(1):7504. PubMed
Wang Q, et al. "Condensin Smc4 promotes inflammatory innate immune response by epigenetically enhancing NEMO transcription." J Autoimmun. 2018 Aug;92:67-76. PubMed
Fujii M, et al. "Human Intestinal Organoids Maintain Self-Renewal Capacity and Cellular Diversity in Niche-Inspired Culture Condition." Cell Stem Cell. 2018 Dec 6;23(6):787-793.e6. PubMed
Klann TS, et al. "Screening Regulatory Element Function with CRISPR/Cas9-based Epigenome Editing." Methods Mol Biol. 2018;1767:447-480. PubMed
Kalem MC, et al. "Gene expression to mitochondrial metabolism: Variability among cultured Trypanosoma cruzi strains." PLoS One. 2018 May 30;13(5):e0197983. PubMed
Klann TS, et al. "CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome." Nat Biotechnol. 2017 Jun;35(6):561-568. PubMed
Okada M, et al. "Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells." Cell Rep. 2017 Aug 1;20(5):1017-1028. PubMed
Li H, et al. "Classifying Drosophila Olfactory Projection Neuron Subtypes by Single-Cell RNA Sequencing." Cell. 2017 Nov 16;171(5):1206-1220.e22. PubMed
Goto T, et al. "Hypomorphic phenotype of Foxn1 gene-modified rats by CRISPR/Cas9 system." Transgenic Res. 2016 Aug;25(4):533-44. PubMed
Oakes BL, et al. "Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch." Nat Biotechnol. 2016 Jun;34(6):646-51. PubMed
Sluch VM, et al. "Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line." Sci Rep. 2015 Nov 13;5:16595. PubMed
Oakes BL, et al. "Protein engineering of Cas9 for enhanced function." Methods Enzymol. 2014;546:491-511. PubMed